- Category
- Small (2024-25)
- Udyam number
- UDYAM-GJ-01-0018892

About Axio Biosolutions Private Limited
Data last updated:
Axio Biosolutions Private Limited is a private limited company based in Ahmedabad, Gujarat, India, a subsidiary of Advamedica Inc. It operates in the medical consumables and supplies segment of the healthcare sector. It was incorporated on 16 May 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U73100GJ2008PTC053905. Its GSTIN is 24AAHCA0497M1ZF (Gujarat). The company holds 4 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹2.71 Cr. It is led by directors Gourav Jagdishchandra Maheshwari and Leo Sebastian Mavely.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No 18 Gujarat Pharma Techno Park Sari – Motoda Ta: Sanand, Ahmedabad, Gujarat, India – 382220.
As per the financials filed for FY 2024, the company reported a revenue of ₹19.9 Cr, a decline of 17% compared to the previous year. For the same year it recorded a net loss of ₹2.71 Cr (net margin -13.6%) and EBITDA of -₹1.89 Cr (EBITDA margin -9.5%). Revenue has grown at a compounded annual rate (CAGR) of 15% over three years and 14% over five years.
The company has about 86 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: AxioBio. As per MCA filings, the company has open charges of ₹7.84 Cr and satisfied charges of ₹10.26 Cr on record. Court records list 4 cases involving the company, including 4 filed against it; 1 case is pending. The company has 11 deals on record (8 funding rounds, 3 secondary share transfers), with disclosed funding of ₹60.88 Cr; the latest was in October 2021. Its 3 peer companies in the Healthcare industry (Medical Consumables), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger; the largest is Magnum Health and Safety Private Limited with revenue of ₹20.31 Cr.
Axio Biosolutions Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0018892). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website axiobio.com.
Company details
Recognitions & Rankings of Axio Biosolutions
Contact details
Axio Biosolutions Private Limited's registered office is in Ahmedabad, Gujarat. Its website is axiobio.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No 18 Gujarat Pharma Techno Park Sari – Motoda Ta: Sanand, Ahmedabad, Gujarat, India – 382220
- IndustryHealthcare, Medical Consumables & Supplies
To see the full contact details of Axio Biosolutions Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Axio Biosolutions operates one associated brand: AxioBio. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Developer of advanced haemostat and wound care dressing products | axiobio.com |
Business activity
The main business activities of Axio Biosolutions are manufacturing and professional, scientific and technical. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and scientific research and development. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Axio Biosolutions Private Limited, buy the company report.
Financials of Axio Biosolutions Private Limited
FY 2024 filings availableAxio Biosolutions Private Limited reported revenue of ₹19.9 Cr (down 17% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 17% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 14%. EBITDA rose 60% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.89 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.71 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -9.5% | ||||
| Net Profit Margin | -13.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Axio Biosolutions Private Limited, buy the company report.
Board of directors of Axio Biosolutions Private Limited
Axio Biosolutions has 2 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gourav Jagdishchandra Maheshwari | Director | 16 May 2018 | 8 Years 6 Months | Current |
| Leo Sebastian Mavely Also directs: Leyam Enterprises LLP | Director | 16 May 2008 | 18 Years 6 Months | Current |
Peer comparison
Axio Biosolutions Private Limited is compared with the 3 companies closest to it by revenue in the Healthcare industry (Medical Consumables), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Magnum Health and Safety Private Limited | ₹20.31 Cr (FY 2025) | -58.0% | Mumbai, Maharashtra, India | |||
| Mt.Derm Medical Products Private Limited | ₹20.29 Cr (FY 2025) | -11.0% | Guduvanchery, Tamil Nadu, India | |||
| Ashri Medico Surgicals Private Limited | ₹20.03 Cr (FY 2025) | 27.0% | Indore, Madhya Pradesh, India | |||
| Axio Biosolutions Private Limitedthis company | ₹19.9 Cr (FY 2024) | -₹2.71 Cr | -13.6% | -17.0% | 86 | Ahmedabad, Gujarat, India |
To see the full peer comparison of Axio Biosolutions Private Limited, buy the company report.
Auditor
Axio Biosolutions Private Limited is audited by S.R. BATLIBOI & ASSOCIATES LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S.R. BATLIBOI & ASSOCIATES LLP | FY 2023 | 0101049W |
Shareholding
The shareholding of Axio Biosolutions Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Axio Biosolutions Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 May 2023 | 100727750 | Others | ₹7.84 Cr | Satisfied | |
| 18 Oct 2013 | 10456848 | Technology Development Board | ₹1.33 Cr | Satisfied | |
| 28 Jun 2010 | 10227078 | Gvfl Trustee Company Private Limited | ₹1.09 Cr | Satisfied |
To see the full charge records of Axio Biosolutions Private Limited, buy the company report.
Total charge records: 3 View all charges
Deals & funding
Axio Biosolutions Private Limited has 11 deals on record (8 funding rounds, 3 secondary share transfers), with disclosed funding of ₹60.88 Cr; the latest was in October 2021.
Deals on record (5 of 11)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Oct 2021 | Funding round | ₹22.05 Cr | Investors: Advamedica Inc |
| Feb 2020 | Funding round | ₹17.71 Cr | Investors: Advamedica Inc |
| Sep 2018 | Funding round | ₹10.8 Cr | Investors: Advamedica Inc |
| Jun 2016 | Secondary share transfer | Undisclosed | Seller: Advamedica Inc |
| May 2016 | Secondary share transfer | Undisclosed | Buyer: Advamedica Inc Seller: GVFL, 3 individuals |
To see the full deal history of Axio Biosolutions Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Axio Biosolutions Private Limited has 4 court cases on record: 4 filed against it. 1 case is pending and 3 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 4 | 1 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, BENGALURU, Karnataka | Court case (Com.O.S.) | Filed against the company by Shoogloo Network Private Limited | Disposed |
| District court, Ahmedabad, Gujarat | Commercial matter | Filed against the company by individuals | Pending |
| District court, Ahmedabad, Gujarat | Court case (SMST R) | Filed against the company by individuals | Disposed |
| District court, South East, Delhi | Commercial suit | Filed against the company by M/S Axiom Meditech Through Its Proprietor Naresh Kumar Bedi | Disposed |
To see the full case history of Axio Biosolutions Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Axio Biosolutions Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Axio Biosolutions Private Limited has a workforce of 86 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 86 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Axio Biosolutions Private Limited, buy the company report.
GST
Axio Biosolutions has 4 GST registrations: 2 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAHCA0497M1ZF | Gujarat | Active | 01 Jul 2017 |
| 29AAHCA0497M2Z4 | Karnataka | Active | 13 Jul 2018 |
To see the full GST registrations and return filing status of Axio Biosolutions Private Limited, buy the company report.
Recent activity
Axio Biosolutions Private Limited has 9 board changes on record since 2008: 2 appointments and 7 cessations. The latest: Sebastian Joseph Mavely ceased to be Director on 26 Aug 2019.
7 earlier events are in the company report.
News
Frequently asked questions
Axio Biosolutions is an active private limited company based in Ahmedabad, Gujarat, India. The company works in medical consumables and supplies, within the healthcare industry. It was incorporated on 16 May 2008 (18+ years old) and is registered under CIN U73100GJ2008PTC053905.
Axio Biosolutions has 2 current directors:
- Gourav Jagdishchandra Maheshwari - Director
- Leo Sebastian Mavely - Director
The latest financial statements of Axio Biosolutions on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Axio Biosolutions is 24AAHCA0497M1ZF, registered in Gujarat. The company has 4 GST registrations in all, of which 2 are active and 2 are cancelled or inactive. Other active GSTINs include 29AAHCA0497M2Z4 (Karnataka).
The CIN (Corporate Identification Number) of Axio Biosolutions is U73100GJ2008PTC053905. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Axio Biosolutions has 4 court cases on record: 4 filed against it. 1 is pending.
Axio Biosolutions was incorporated on 16 May 2008, making it 18+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Axio Biosolutions has 11 deals on record (8 funding rounds, 3 secondary share transfers), with disclosed funding of ₹60.88 Cr; the latest was in October 2021.
The peers of Axio Biosolutions by revenue are Magnum Health and Safety Private Limited, Mt.Derm Medical Products Private Limited, Ashri Medico Surgicals Private Limited, all in the Healthcare industry (Medical Consumables), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sebastian Joseph Mavely ceased to be Director on 26 Aug 2019. Gourav Jagdishchandra Maheshwari ceased to be Additional Director on 28 Sep 2018. Gourav Jagdishchandra Maheshwari was appointed as Director on 16 May 2018. Axio Biosolutions has 9 board changes on record in total.
Yes, Axio Biosolutions is registered as a small enterprise under Udyam registration (number: UDYAM-GJ-01-0018892).

